BDSX - Biodesix spikes on a series of insider purchases

The shares of lung test maker, Biodesix (NASDAQ:BDSX) have climbed ~50% in the pre-market Tuesday in reaction to multiple insider purchases made by certain members of the company management. In regulatory filings submitted on Monday, Biodesix (BDSX) Chairman John Patience and board members Jack Schuler and Matthew Strobeck disclosed the purchases made on April 07. Patience has bought ~279.4K shares at $1.79 apiece to increase his stake by ~6% to nearly $500K, while Schuler and Strobeck purchased ~2.7M and ~1.1M shares at a similar price to increase their stake by ~33% and ~88% to $5.0M and $2.0M, respectively. The announcements of insider purchases came shortly after Biodesix (BDSX) said it raised more than $11M through a private placement on April 07. The net proceeds were intended for debt repayment and general corporate purposes.

For further details see:

Biodesix spikes on a series of insider purchases